Skip to main content
Caplight Logo









Cogitat

Cogitat

Private
RoystonHealthcare & Life Scienceshttps://cogitat.io/

Last Round

Accelerator

Sep 3, 2025

Total Funding Raised

$2.28M

Company Overview

Cogitat is a neurotechnology company that develops device-agnostic AI software to convert brain waves into digital commands for brain-computer interface applications.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Devices, Defense Tech, Health IoT

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

brain-computer interfaceBCIEEG decodingneurotechnologymind controlneurorehabilitationtelerehabilitationattention monitoringcognitive performancewearable neurotechnon-invasive BCIbrainwave controlmedical AIthought-to-textneural interface

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cogitat Comparables

Compare Cogitat with similar companies based on industry and business-model similarity.

Cogitat comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Arctop
77%
g.tec medical engineering
70%
Emotiv
69%

Cogitat Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorSep 3, 2025
AcceleratorJul 7, 2025
AcceleratorJan 10, 2025
AcceleratorDec 11, 2024
AcceleratorJul 1, 2024
Grant
Jun 19, 2023

Key People

Founding team and executive leadership

Dimitrios Adamos

Co-Founder and Chief Technology Officer

Founding Team

Allan Ponniah

Chief Executive Officer

Executive Team

Cogitat Investors

Notable investors and investment history

Cogitat investors
InvestorRounds
Innovate UKAccelerator, Grant
Cambridge AngelsPre Seed
DIANAAccelerator
Pioneer GroupAccelerator
Creative Destruction LabAccelerator
Innovate UKAccelerator, Grant
MetavallonPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 6, 2026

    Monthly visitors grew 38% MoM, from 619 to 856.

  • Sep 3, 2025

    $125K round from Pioneer Group and Innovate UK.

Cogitat Filings

Explore SEC and related filing metadata, where available.

Cogitat filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cogitat's valuation, stock price, and market status.

Is Cogitat a public or private company?

Cogitat is a private company.

What is the current stock price of Cogitat?

Cogitat is a private company with no public stock price. No recent secondary market data is available.

How much is Cogitat worth (valuation)?

Valuation information for Cogitat is not publicly available.

Can I buy Cogitat stock?

Cogitat shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Cogitat's last funding round?

Cogitat's most recent funding round was Accelerator on July 7, 2025.

Who are the main investors in Cogitat?

Key investors in Cogitat include Innovate UK.

Will Cogitat IPO soon?

No public IPO plans have been announced for Cogitat.

How can I track Cogitat secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cogitat's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersRoyston
Employee Range14
Year Founded2020
Last FundingSep 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?